Examples of 'prolonged-release' in a sentence
Meaning of "prolonged-release"
Prolonged-release (noun): A type of medication or substance designed to be released slowly into the body over an extended period of time, providing a sustained effect
How to use "prolonged-release" in a sentence
Basic
Advanced
prolonged-release
Do not chew your prolonged-release tablets.
Prolonged-release exenatide is not recommended in these patients.
Clinical studies with prolonged-release tablets.
Ranexa prolonged-release tablets are oval shaped tablets.
Toviaz tablets are known as prolonged-release tablets.
Viramune prolonged-release tablets dose mg.
Excipients for all ranolazine prolonged-release tablets.
Buvidal is a prolonged-release solution for injection.
Your medicine is in the form of prolonged-release tablets.
Prolonged-release suspension for injection.
Zycortal is available as a prolonged-release suspension for injection.
The prolonged-release tablet should not be divided.
This may be achieved by prolonged-release opioid formulations.
Prolonged-release exenatide is not a substitute for insulin.
Tacforius is available as prolonged-release capsules containing tacrolimus.
See also
Prolonged-release micropillules in hard capsule.
The efficacy of venlafaxine prolonged-release as a.
Mg prolonged-release solution for injection.
This medication is available in the form of prolonged-release capsule.
Prolonged-release paracetamol withdrawn from the market.
Powder and solvent for prolonged-release suspension for injection.
Prolonged-release formulations can be given once or twice daily.
No information is available for prolonged-release quetiapine in children and adolescents.
Prolonged-release powder and solvent for solution for injection.
It was to be available as a prolonged-release solution for injection under the skin in cattle.
Prolonged-release microcapsule and solvent for suspension for injection.
Inadvertent, unintentional or unsupervised switching of immediate - or prolonged-release formulations of tacrolimus is unsafe.
Viramune prolonged-release tablets contain lactose milk sugar.
There are no adequate data from the use of prolonged-release exenatide in pregnant women.
The prolonged-release tablets must not be broken or chewed.
Most adverse reactions associated with prolonged-release exenatide were mild to moderate in intensity.
Prolonged-release exenatide must not be administered by intravenous or intramuscular injection.
Bydureon 2 mg powder and solvent for prolonged-release suspension for injection exenatide.
Prolonged-release exenatide has shown no adverse effects on lipid parameters.
The tablet matrix maintains its prolonged-release properties as long as it is ingested as a whole.
Prolonged-release exenatide that has been frozen must not be used.
There have been spontaneously reported events of acute pancreatitis with prolonged-release exenatide.
This medicinal product is a prolonged-release formulation containing 2 mg of synthetic melatonin.
Gender has no clinically meaningful effect on pharmacokinetics of nicotinic acid prolonged-release formulation.
Viramune prolonged-release tablets can be taken with or without food.
There were no episodes of major hypoglycaemia in the prolonged-release exenatide with insulin group.
A prolonged-release form is only obtained in the case of intramuscular injection.
The pharmacokinetic properties of doxazosin in prolonged-release tablets lead to a minor variation in plasma levels.
Prolonged-release compositions comprising torasemide and a matrix-forming polymer.
Thereafter, the patient is transferred to the same daily dose using prolonged-release tablets.
Rate based on prolonged-release exenatide spontaneous reports data unknown denominator.
A reduction in body weight compared to baseline has been observed in all prolonged-release exenatide studies.
The use of prolonged-release exenatide does not require additional self-monitoring.
Food had no effect on darifenacin pharmacokinetics during multiple-dose administration of prolonged-release tablets.
Prolonged-release exenatide demonstrated a superior change in HbA1c compared to insulin glargine.